Cargando…
Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux
The residual risk for arteriosclerotic cardiovascular disease after optimal statin treatment may amount to 50% and is the consequence of both immunological and lipid disturbances. Regarding the lipid disturbances, the role of triglyceride-rich lipoproteins (TRLs) and their remnants has come to the f...
Autor principal: | Gugliucci, Alejandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342861/ https://www.ncbi.nlm.nih.gov/pubmed/37445434 http://dx.doi.org/10.3390/jcm12134399 |
Ejemplares similares
-
Beyond LDL: Understanding Triglyceride-Rich Lipoproteins to Tackle Residual Risk
por: Gugliucci, Alejandro
Publicado: (2023) -
PCSK9 and triglyceride-rich lipoprotein metabolism
por: Druce, Irena, et al.
Publicado: (2015) -
Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis
por: Zhang, Bai-Hui, et al.
Publicado: (2022) -
Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk
por: Baratta, Francesco, et al.
Publicado: (2023) -
Triglyceride-Rich Lipoproteins and Remnant Cholesterol in Cardiovascular Disease
por: Heo, Ji Hye, et al.
Publicado: (2023)